Terminix Global Holdings Inc (TMX)

US88087E1001 - Common Stock

37.87  -0.19 (-0.5%)

After market: 37.7 -0.17 (-0.45%)

Fundamental Rating

2

Overall TMX gets a fundamental rating of 2 out of 10. We evaluated TMX against 66 industry peers in the Diversified Consumer Services industry. TMX may be in some trouble as it scores bad on both profitability and health. TMX is valied quite expensively at the moment, while it does show a decent growth rate.



2

1. Profitability

1.1 Basic Checks

TMX had positive earnings in the past year.
In the past year TMX had a positive cash flow from operations.
Of the past 5 years TMX 4 years were profitable.
TMX had a positive operating cash flow in 4 of the past 5 years.

1.2 Ratios

Industry RankSector Rank
ROA 1.47%
ROE 2.71%
ROIC 4.91%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

TMX's Profit Margin has declined in the last couple of years.
TMX's Operating Margin has declined in the last couple of years.
Industry RankSector Rank
OM 11.7%
PM (TTM) 3.15%
GM N/A
OM growth 3Y-6.56%
OM growth 5Y-5.92%
PM growth 3Y-0.81%
PM growth 5Y-32.41%
GM growth 3YN/A
GM growth 5YN/A

3

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), TMX is destroying value.
The number of shares outstanding for TMX has been reduced compared to 1 year ago.
The debt/assets ratio for TMX is higher compared to a year ago.

2.2 Solvency

TMX has an Altman-Z score of 2.34. This is not the best score and indicates that TMX is in the grey zone with still only limited risk for bankruptcy at the moment.
TMX has a debt to FCF ratio of 3.69. This is a good value and a sign of high solvency as TMX would need 3.69 years to pay back of all of its debts.
TMX has a Debt/Equity ratio of 0.35. This is a healthy value indicating a solid balance between debt and equity.
Industry RankSector Rank
Debt/Equity 0.35
Debt/FCF 3.69
Altman-Z 2.34
ROIC/WACC0.55
WACC8.94%

2.3 Liquidity

TMX has a Current Ratio of 1.28. This is a normal value and indicates that TMX is financially healthy and should not expect problems in meeting its short term obligations.
TMX has a Quick Ratio of 1.20. This is a normal value and indicates that TMX is financially healthy and should not expect problems in meeting its short term obligations.
Industry RankSector Rank
Current Ratio 1.28
Quick Ratio 1.2

4

3. Growth

3.1 Past

TMX shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 14.84%, which is quite good.
The Earnings Per Share has been decreasing by -6.99% on average over the past years.
Looking at the last year, TMX shows a small growth in Revenue. The Revenue has grown by 4.60% in the last year.
Measured over the past years, TMX shows a decrease in Revenue. The Revenue has been decreasing by -5.72% on average per year.
EPS 1Y (TTM)14.84%
EPS 3Y-12.09%
EPS 5Y-6.99%
EPS growth Q2Q0%
Revenue 1Y (TTM)4.6%
Revenue growth 3Y2.48%
Revenue growth 5Y-5.72%
Revenue growth Q2Q4.46%

3.2 Future

TMX is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 8.74% yearly.
Based on estimates for the next years, TMX will show a small growth in Revenue. The Revenue will grow by 3.89% on average per year.
EPS Next Y4.41%
EPS Next 2Y6.42%
EPS Next 3Y8.18%
EPS Next 5Y8.74%
Revenue Next Year3.74%
Revenue Next 2Y3.68%
Revenue Next 3Y4.03%
Revenue Next 5Y3.89%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.

1

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 25.76, the valuation of TMX can be described as expensive.
TMX is valuated at similar levels of the S&P average when we compare the Price/Earnings ratio to 28.83, which is the current average of the S&P500 Index.
A Price/Forward Earnings ratio of 23.55 indicates a rather expensive valuation of TMX.
TMX is valuated at similar levels of the S&P average when we compare the Price/Forward Earnings ratio to 20.47, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 25.76
Fwd PE 23.55

4.2 Price Multiples

Industry RankSector Rank
P/FCF 19.02
EV/EBITDA 14.7

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates TMX does not grow enough to justify the current Price/Earnings ratio.
PEG (NY)5.84
PEG (5Y)N/A
EPS Next 2Y6.42%
EPS Next 3Y8.18%

0

5. Dividend

5.1 Amount

No dividends for TMX!.
Industry RankSector Rank
Dividend Yield N/A

Terminix Global Holdings Inc

NYSE:TMX (10/11/2022, 7:04:00 PM)

After market: 37.7 -0.17 (-0.45%)

37.87

-0.19 (-0.5%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Services
GICS IndustryDiversified Consumer Services
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap4.60B
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE 25.76
Fwd PE 23.55
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)5.84
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 1.47%
ROE 2.71%
ROCE
ROIC
ROICexc
ROICexgc
OM 11.7%
PM (TTM) 3.15%
GM N/A
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.47
Health
Industry RankSector Rank
Debt/Equity 0.35
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 1.28
Quick Ratio 1.2
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)14.84%
EPS 3Y-12.09%
EPS 5Y
EPS growth Q2Q
EPS Next Y4.41%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)4.6%
Revenue growth 3Y2.48%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y